Skip to Main Content
Legislation Search

H.R. 4531: Support for Patients and Communities Reauthorization Act

Sponsors

67 bill sponsors

Actions

15 actions

Date Action
Dec. 13, 2023 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec. 12, 2023 Considered as unfinished business. (consideration: CR H6836)
Dec. 12, 2023 Motion to reconsider laid on the table Agreed to without objection.
Dec. 12, 2023 On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 386 - 37 (Roll no. 715). (text: 12/11/2023 CR H6790-6794)
Dec. 12, 2023 Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 386 - 37 (Roll no. 715). (text: 12/11/2023 CR H6790-6794)
Dec. 11, 2023 At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Dec. 11, 2023 Considered under suspension of the rules. (consideration: CR H6789-6797)
Dec. 11, 2023 DEBATE - The House proceeded with forty minutes of debate on H.R. 4531.
Dec. 11, 2023 Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Sep. 28, 2023 Committee Consideration and Mark-up Session Held
Sep. 28, 2023 Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 29 - 3.
Jul. 19, 2023 Committee Consideration and Mark-up Session Held.
Jul. 19, 2023 Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
Jul. 11, 2023 Introduced in House
Jul. 11, 2023 Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

No relevant congressional stock trades found.